1-20 of 156
Felipe Samaniego
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nivolumab and Ibrutinib for Treatment of Patients with Refractory or Relapsed Central Nervous System Lymphoma

Jason Westin, Ranjit Nair, Luis Fayad, Swami P. Iyer, Luis Malpica, Sattva S. Neelapu, Felipe Samaniego, Raphael Eric Steiner, Paolo Strati, Shivon Mathew, Donna Griffith, Loretta J. Nastoupil, Wirt Montinez, Maria Alma Rodriguez, Frederick Hagemeister, Lei Feng, Francisco Vega, Christopher R. Flowers, Sairah Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 1721.
https://doi.org/10.1182/blood-2023-191123
Published: 2023
Journal Articles

Phase 1 Dose Escalation Study of Pembrolizumab in Combination with Rituximab and Lenalidomide for Relapsed/Refractory Large B-Cell or Follicular Lymphoma Following Progression after Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy

Dustin McCurry, Jason Westin, Lei Feng, Sairah Ahmed, Ranjit Nair, Raphael Eric Steiner, Lauren Wynn, Jennifer Thomas, Ly Huynh Dsouza, Felipe Samaniego, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 4466.
https://doi.org/10.1182/blood-2023-182978
Published: 2023
Journal Articles

A Phase 1a/b Trial of Luxeptinib (CG-806) in Patients with Relapsed/Refractory B-Cell Malignancies or Acute Myeloid Leukemia and Evaluation of New G3 Formulation

Aaron D. Goldberg, Felipe Samaniego, Maro Ohanian, Paul B. Koller, Namrata Sonia Chandhok, Ahad A. Sadiq, Daruka Mahadevan, Mohamad A. Cherry, Jessica K. Altman, John M. Burke, Michael Z. Koontz, J. C. C Villasboas, Ben K. Tomlinson, Laura E. Finn, Erin G Reid, Jason Melear, Victor Priego, Patrick Cobb, Elizabeth Heritage Cull, Paul Conkling, David Cosgrove, Lindsey E. Roeker, Eric Tam, Donna Nguyen Haney, Jia Hu, Ranjeet Sinha, Nawazish Khan, William G. Rice, Rafael Bejar
Journal: Blood
Blood (2023) 142 (Supplement 1): 5953.
https://doi.org/10.1182/blood-2023-181151
Published: 2023
Journal Articles

Crebbp Kat Domain Missense Mutations Alter Its Dynamic Loading Onto Chromatin and Create a Transcription Factor Sink

Haopeng Yang, Wenchao Zhang, Vida Ravanmehr, Jared Henderson, Qing Deng, Felipe Samaniego, Fernando Rodrigues-Lima, Michael R Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 8768–8769.
https://doi.org/10.1182/blood-2022-166230
Published: 2022
Journal Articles

Phase II Study of Pembrolizumab and Fractionated External Beam Radiotherapy in Patients with Relapsed and Refractory Large B-Cell Lymphoma

Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Penny Fang, Susan Wu, Sairah Ahmed, Raphael E Steiner, Ranjit Nair, Paolo Strati, Jason Westin, Luis Fayad, Swami P. Iyer, Maria Alma Rodriguez, Hun Ju Lee, Felipe Samaniego, Dai Chihara, Preetesh Jain, Lei Feng, Christopher R. Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood
Blood (2022) 140 (Supplement 1): 3741–3743.
https://doi.org/10.1182/blood-2022-168540
Published: 2022
Journal Articles

Primary Analysis of a Pilot Study of Prophylactic Anakinra to Mitigate CAR T Cell-Associated Toxicity in Patients with Relapsed or Refractory Large B-Cell Lymphoma

Paolo Strati, Xubin Li, Qing Deng, Lei Feng, Ryan Sun, Andrew Jallouk, Sherry Adkins, Taylor Cain, Swapna Johncy, Raphael E Steiner, Sairah Ahmed, Dai Chihara, Luis Fayad, Swaminathan Padmanabhan Iyer, Sandra B. Horowitz, Rachel Nehlsen, Loretta J. Nastoupil, Ranjit Nair, Ahmed Hassan, Taher Daoud, Misha Hawkins, Felipe Samaniego, Maria Alma Rodriguez, Elizabeth J Shpall, Partow Kebriaei, Christopher R. Flowers, David Hong, Jason Westin, Sattva S. Neelapu, Michael R. Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 7493–7495.
https://doi.org/10.1182/blood-2022-157448
Published: 2022
Journal Articles

Safety and Efficacy of the PI3Kδ Inhibitor Zandelisib in Combination with the BTK Inhibitor Zanubrutinib in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Mantle Cell Lymphoma (MCL)

Jacob D. Soumerai, Catherine S. Diefenbach, Felipe Samaniego, Abhijeet Kumar, Michaela L. Tsai, Adam S. Asch, Deepa Jagadeesh, Vaishalee P. Kenkre, Izidore S. Lossos, Huda Salman, Farrukh T. Awan, Lu Miao, Richard G. Ghalie, Andrew D. Zelenetz
Journal: Blood
Blood (2022) 140 (Supplement 1): 189–191.
https://doi.org/10.1182/blood-2022-157563
Published: 2022
Journal Articles

Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis

Owhofasa O. Agbedia, Rishab Prakash, Jie Xu, Melody R. Becnel, Ranjit Nair, Raphael E Steiner, Lei Feng, Hun Ju Lee, Paolo Strati, Sairah Ahmed, Simrit Parmar, Yago Nieto, Chitra Hosing, Jason Westin, Loretta J. Nastoupil, Ann Vo, Felipe Samaniego, Nathan H. Fowler, Neeraj Saini, Issa F. Khouri, Jin S. Im, Luis Fayad, Preetesh Jain, Michael L. Wang, Roberto N. Miranda, Francisco Vega, Jeffrey Medeiros, Yasuhiro Oki, Christopher R. Flowers, Sattva S. Neelapu, Swaminathan P. Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2313–2315.
https://doi.org/10.1182/blood-2022-168983
Published: 2022
Journal Articles

A Phase 1a/b Dose Escalation Study of the BTK/FLT3 Inhibitor Luxeptinib in Patients with Relapsed or Refractory B-Cell Malignancies

Felipe Samaniego, Ahad A. Sadiq, Daruka Mahadevan, Michael Z. Koontz, Jose C. Villasboas, John M. Burke, Erin G Reid, Mohamad Cherry, Jason Melear, Victor Priego, Patrick Cobb, Elizabeth H. Cull, Paul Conkling, David Cosgrove, Lindsey E. Roeker, Donna Nguyen Haney, Jia Hu, Ranjeet Kumar Sinha, William G Rice, Rafael Bejar
Journal: Blood
Blood (2022) 140 (Supplement 1): 6498–6500.
https://doi.org/10.1182/blood-2022-163683
Published: 2022
Journal Articles

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

Hua-Jay J. Cherng, Ryan Sun, Bryant Sugg, Russell Irwin, Haopeng Yang, Cao Cuong Le, Qing Deng, Luis Fayad, Nathan H. Fowler, Simrit Parmar, Raphael Steiner, Fredrick Hagemeister, Ranjit Nair, Hun Ju Lee, Maria Rodriguez, Felipe Samaniego, Swaminathan P. Iyer, Christopher R. Flowers, Linghua Wang, Loretta J. Nastoupil, Sattva S. Neelapu, Sairah Ahmed, Paolo Strati, Michael R. Green, Jason Westin
Journal: Blood
Blood (2022) 140 (5): 504–515.
https://doi.org/10.1182/blood.2022015601
Published: 2022
Includes: Supplemental data
Journal Articles

A Risk Score Incorporating Low Pass Whole Genome Sequencing of Cell Free DNA from Patients Receiving CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma

Hua-Jay J. Cherng, Ryan Sun, Haopeng Yang, Qing Deng, Luis Fayad, Nathan H. Fowler, Simrit Parmar, Sairah Ahmed, Raphael E Steiner, Fredrick B. Hagemeister, Hun Ju Lee, Ranjit Nair, Maria Alma Rodriguez, Felipe Samaniego, Swaminathan P Iyer, Loretta Nastoupil, Sattva S. Neelapu, Paolo Strati, Jason R. Westin, Michael R Green
Journal: Blood
Blood (2021) 138 (Supplement 1): 38.
https://doi.org/10.1182/blood-2021-148314
Published: 2021
Journal Articles

Phase II Trial of Response Adapted Ultra Low Dose (ULD) Orbital Radiation Therapy for Indolent B Cell Lymphoma

Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Penny Fang, Susan Wu, Loretta Nastoupil, Paolo Strati, Ranjit Nair, Sairah Ahmed, Raphael E Steiner, Luis Malpica-Castillo, Dai Chihara, Preetesh Jain, Luis Fayad, Jason R. Westin, Sattva S. Neelapu, Maria Alma Rodriguez, Fredrick B. Hagemeister, Hun Ju Lee, Michael Wang, Felipe Samaniego, Nathan H. Fowler, Christopher R. Flowers, Lei Feng, Linda Chi, Bita Esmaeli
Journal: Blood
Blood (2021) 138 (Supplement 1): 3526.
https://doi.org/10.1182/blood-2021-154172
Published: 2021
Journal Articles

Ibrutinib Plus Rituximab and Venetoclax (IRV) Followed By Risk-Stratified Observation or Short Course R-Hypercvad/MTX in Young Patients with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-2 Clinical Trial

Michael Wang, Preetesh Jain, Hun Ju Lee, Chi Young Ok, Holly Hill, Lucy Navsaria, Rashmi Kanagal-Shamanna, Luis Malpica-Castillo, Ranjit Nair, Swaminathan Padmanabhan Iyer, Felipe Samaniego, Wendy Chen, Onyeka Oriabure, Lei Feng, Selvi Thirumurthi, David Santos, Guilin Tang, Francisco Vega, Shaoying Li, Michelle Avellaneda, Maria Badillo, Christopher R. Flowers
Journal: Blood
Blood (2021) 138 (Supplement 1): 3525.
https://doi.org/10.1182/blood-2021-153390
Published: 2021
Journal Articles

Ten Year Follow up of the MD Anderson Cancer Center Phase 2 Study of Rituximab in Combination with Lenalidomide (R2) for Patients with Low Tumor Burden Follicular Lymphoma

Dai Chihara, Loretta Nastoupil, Paolo Strati, Felipe Samaniego, Lei Feng, Maria Alma Rodriguez, Luis Fayad, Jason R. Westin, Fredrick B. Hagemeister, Michael Wang, Sattva S. Neelapu, Nathan H. Fowler
Journal: Blood
Blood (2021) 138 (Supplement 1): 3532.
https://doi.org/10.1182/blood-2021-149293
Published: 2021
Journal Articles

Long Term Outcome Patterns and Risk Factors for Early Mortality and Disease Progression in ALK-Positive Anaplastic Large Cell Lymphoma

Luis Malpica-Castillo, Lei Feng, Jie Xu, Ranjit Nair, Alexandra Elias, Preetesh Jain, Dai Chihara, Raphael Steiner, Luis Fayad, Felipe Samaniego, Sairah Ahmed, Nathan H. Fowler, Loretta Nastoupil, Samer A. Srour, Yago Nieto, Chitra Hosing, Roberto N. Miranda, Francisco Vega, Chelsea C. Pinnix, Jillian R. Gunther, Penny Fang, Susan Wu, Bouthaina S. Dabaja, Jeffrey Medeiros, Michael Wang, Sattva S. Neelapu, Christopher R. Flowers, Swaminathan Padmanabhan Iyer
Journal: Blood
Blood (2021) 138 (Supplement 1): 2463.
https://doi.org/10.1182/blood-2021-150798
Published: 2021
Journal Articles

The Combination of Umbralisib Plus Ublituximab Is Active in Patients with Relapsed or Refractory Marginal Zone Lymphoma (MZL): Results from the Phase 2 Global Unity-NHL Trial

Julio C. Chavez, Neta Goldschmidt, Felipe Samaniego, Tomasz Wrobel, Federica Cavallo, Gustavo Fonseca, Sung-Soo Yoon, Lubos Drgona, Eliza Hawkes, Itai Levi, Hari P. Miskin, Peter Sportelli, Owen A. O'Connor, Nathan H. Fowler, Pier Luigi Zinzani
Journal: Blood
Blood (2021) 138 (Supplement 1): 45.
https://doi.org/10.1182/blood-2021-147425
Published: 2021
Journal Articles

A Phase 1a/b Dose Escalation Study of the Mutation Agnostic BTK/FLT3 Inhibitor Luxeptinib (CG-806) in Patients with Relapsed or Refractory B-Cell Malignancies

Felipe Samaniego, John M. Burke, Daruka Mahadevan, Mohamad Cherry, Ahad A. Sadiq, M. Zach Koontz, Jose C. Villasboas, Erin Reid, Elizabeth Cull, Victor Priego, Lindsey E. Roeker, Patrick Cobb, Jason Melear, Paul Conkling, David Cosgrove, Hongying Zhang, Nasrin Rastgoo, Khalid Benbatoul, Donna Nguyen Haney, Yuying Jin, Jotin Marango, Stephen B Howell, William G Rice, Rafael Bejar
Journal: Blood
Blood (2021) 138 (Supplement 1): 1355.
https://doi.org/10.1182/blood-2021-148827
Published: 2021
Journal Articles

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

Brief Report
Paolo Strati, Sairah Ahmed, Fateeha Furqan, Luis E. Fayad, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sandra B. Horowitz, Lei Feng, Ryan Sun, Catherine M. Claussen, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J. Shpall, Michael R. Green, Christopher R. Flowers, Jason Westin, Sattva S. Neelapu
Journal: Blood
Blood (2021) 137 (23): 3272–3276.
https://doi.org/10.1182/blood.2020008865
Published: 2021
Includes: Supplemental data
Journal Articles

Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma

Clinical Trials & Observations
Paolo Strati, Preetesh Jain, Ralph J. Johnson, Sheryl Forbes, Lei Feng, Felipe Samaniego, Maria A. Rodriguez, Luis E. Fayad, Fredrick Hagemeister, Jason Westin, Michael Wang, Sattva S. Neelapu, Loretta J. Nastoupil, Nathan H. Fowler
Journal: Blood
Blood (2021) 137 (8): 1124–1129.
https://doi.org/10.1182/blood.2020007994
Published: 2021
Includes: Supplemental data
Journal Articles

Real Life Treatment Alterations of Frontline Therapies in Classic Hodgkin's Lymphoma

Samer Al Hadidi, MDMSc,FACP, Ranjit Nair, MD, Raphael E Steiner, MD, Sairah Ahmed, MD, Paolo Strati, MD, Simrit Parmar, MD, MSCI, Swami P. Iyer, MD, Jillian R. Gunther, MD PhD, Chelsea C. Pinnix, MD PhD, Bouthaina S. Dabaja, MD, Yago Nieto, MD, Felipe Samaniego, MD, Branko Cuglievan, MD, Preetesh Jain, MBBS,MDDM,PhD, Penny Fang, MD, Roberto N. Miranda, MD, Jeffrey Medeiros, MD, Lei Feng, MS, Hubert Chuang, MDPhD, Michael Wang, MD, Hun Ju Lee, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-134588
Published: 2020